What is the recommended treatment for Shigella diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Shigella Diarrhea

Antibiotic therapy is strongly recommended for Shigella diarrhea, with fluoroquinolones (such as ciprofloxacin) or azithromycin being the first-line treatments based on local susceptibility patterns. 1

Diagnosis and Clinical Presentation

Shigellosis is characterized by:

  • Dysentery with bloody, mucoid stools
  • Abdominal pain and cramping
  • Fever
  • Rectal tenesmus

Diagnosis is primarily clinical but can be confirmed through:

  • Stool examination for white blood cells
  • Stool culture to isolate Shigella species
  • PCR testing in specialized settings

Treatment Algorithm

1. Rehydration Therapy

  • First-line treatment for all patients with Shigella diarrhea is oral rehydration solution (ORS), especially for those with mild to moderate dehydration 2
  • For severe dehydration, intravenous fluids may be necessary

2. Antimicrobial Therapy

Based on the most recent guidelines, antimicrobial therapy is indicated for Shigella infection 2, 1:

For Adults:

  • Ciprofloxacin: 500 mg twice daily for 3-5 days
  • Azithromycin: 1000 mg single dose or 500 mg daily for 3 days
  • TMP-SMX: 160 mg TMP and 800 mg SMX twice daily for 5 days (if susceptible)

For Children:

  • Azithromycin: 12 mg/kg on day 1 (max 500 mg), then 6 mg/kg/day for days 2-5
  • Third-generation cephalosporin for infants <3 months of age
  • TMP-SMX: 10 mg/kg/day TMP and 50 mg/kg/day SMX in two divided doses for 5 days (if susceptible)

Treatment Duration:

  • 3-5 days for immunocompetent patients
  • 7-10 days for immunocompromised patients

3. Nutritional Support

  • Continue feeding during illness
  • Resume normal diet as soon as appetite returns
  • For breastfeeding infants, continue breastfeeding throughout treatment

Special Considerations

Antibiotic Resistance

  • Antibiotic resistance is increasing among Shigella strains globally 3
  • Ciprofloxacin and norfloxacin generally maintain good effectiveness (93.3% susceptibility in recent studies) 3
  • High resistance has been observed for amoxicillin (100%), ampicillin (86.7%), and cotrimoxazole (66.7%) 3
  • Periodic susceptibility testing is recommended, especially in endemic areas

When to Consider Empiric Treatment

Empiric antimicrobial therapy is recommended for 2:

  • Infants <3 months with suspected bacterial etiology
  • Immunocompetent people with fever, abdominal pain, and bloody diarrhea
  • Recent international travelers with fever ≥38.5°C and/or signs of sepsis

Treatment Failure

If no clinical response occurs within 2 days:

  • Change to another recommended antibiotic based on local susceptibility patterns
  • If no improvement after an additional 2 days, consider alternative diagnoses

Prevention and Public Health Measures

  • Hand washing is the single most important preventive measure
  • Proper sanitation and safe drinking water
  • Isolation of hospitalized patients
  • Follow local public health guidelines for return to work, school, or childcare

Complications

Monitor for potential complications such as:

  • Hemolytic uremic syndrome
  • Reactive arthritis
  • Toxic megacolon

These complications require specialized management beyond the standard treatment for shigellosis.

References

Guideline

Shigella Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.